Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series Ltd: World’s leading Event Organizer

Back

Winson Cheung

Winson Cheung

Associate Professor
The University of British Columbia
Canada

Biography

Winson Y. Cheung is a medical oncologist and Associate Professor of Medicine at UBC Division of Medical Oncology of the British Columbia Cancer Agency. He is also the Director of Undergraduate Education at UBC Department of Medicine since February, 2014 and Chair of GI Systemic Therapy at BC Cancer Agency of Vancouver Centre. Winson Y. Cheung received his medical degree at UBC, Medical Oncology training at the University of Toronto and subsequently obtained a Masters of Public Health degree at Harvard University. His area of specialization is in the treatment of head & neck as well as gastrointestinal malignancies. He is the recipient of numerous accolades, including the National Cancer Institute of Canada Dorothy Lamont Award, the Novartis Oncology Canadian Investigator Award, the Multinational Association of Supportive Care in Cancer Investigator Award, and several merit awards from American Society of Clinical Oncology. Winson Y. Cheung has many research publications in reputed scientific journals, engages actively in diverse research projects, and takes great pride in mentoring young trainees, many of whom have subsequently won prizes for their research work.

Research Interest

Winson Y. Cheung’s most recent research projects have focused on the emerging area of geriatric oncology, particularly studying the appropriate use of systemic therapy in elderly cancer patients, as well as treatment disparities and cancer survivorship. His primary research interest is health services and outcomes research with the aim to ensure appropriate access to cancer care and enhance delivery of cancer therapies to all patients. He works closely with large administrative datasets to answer a wide spectrum of relevant clinical research questions. Most recently, he conducted analyses which revealed that expectations for follow-up care between cancer survivors and their physicians were discordant and how this discrepancy may pose a negative impact on patient outcomes.